nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—Night blindness—Varenicline—nicotine dependence	0.0344	0.0406	CcSEcCtD
Alitretinoin—Sensory disturbance—Varenicline—nicotine dependence	0.0261	0.0308	CcSEcCtD
Alitretinoin—Facial paralysis—Varenicline—nicotine dependence	0.0255	0.0301	CcSEcCtD
Alitretinoin—Anger—Varenicline—nicotine dependence	0.0227	0.0268	CcSEcCtD
Alitretinoin—Abnormal behaviour—Varenicline—nicotine dependence	0.0217	0.0257	CcSEcCtD
Alitretinoin—RXRG—cardiovascular system—nicotine dependence	0.0215	0.141	CbGeAlD
Alitretinoin—CRABP1—midbrain—nicotine dependence	0.0213	0.139	CbGeAlD
Alitretinoin—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0197	0.0233	CcSEcCtD
Alitretinoin—Hoarseness—Varenicline—nicotine dependence	0.0184	0.0217	CcSEcCtD
Alitretinoin—Pancreatitis acute—Varenicline—nicotine dependence	0.0175	0.0207	CcSEcCtD
Alitretinoin—RXRG—midbrain—nicotine dependence	0.0168	0.11	CbGeAlD
Alitretinoin—Myositis—Varenicline—nicotine dependence	0.0165	0.0195	CcSEcCtD
Alitretinoin—Suicide—Varenicline—nicotine dependence	0.0156	0.0184	CcSEcCtD
Alitretinoin—Suicide attempt—Varenicline—nicotine dependence	0.0143	0.0168	CcSEcCtD
Alitretinoin—Completed suicide—Varenicline—nicotine dependence	0.0138	0.0163	CcSEcCtD
Alitretinoin—CRABP1—brain—nicotine dependence	0.0134	0.0875	CbGeAlD
Alitretinoin—Upset stomach—Varenicline—nicotine dependence	0.0124	0.0146	CcSEcCtD
Alitretinoin—CRABP2—brain—nicotine dependence	0.0121	0.0791	CbGeAlD
Alitretinoin—RXRA—brain—nicotine dependence	0.012	0.0787	CbGeAlD
Alitretinoin—Menstrual disorder—Varenicline—nicotine dependence	0.0119	0.014	CcSEcCtD
Alitretinoin—Suicidal ideation—Varenicline—nicotine dependence	0.0116	0.0136	CcSEcCtD
Alitretinoin—Thrombosis—Varenicline—nicotine dependence	0.0114	0.0135	CcSEcCtD
Alitretinoin—Hyperlipidaemia—Varenicline—nicotine dependence	0.0112	0.0133	CcSEcCtD
Alitretinoin—RARB—brain—nicotine dependence	0.0108	0.0707	CbGeAlD
Alitretinoin—Scotoma—Varenicline—nicotine dependence	0.0107	0.0126	CcSEcCtD
Alitretinoin—RXRG—brain—nicotine dependence	0.0106	0.0691	CbGeAlD
Alitretinoin—Gingivitis—Varenicline—nicotine dependence	0.0103	0.0122	CcSEcCtD
Alitretinoin—RXRB—brain—nicotine dependence	0.00993	0.065	CbGeAlD
Alitretinoin—Dysphonia—Varenicline—nicotine dependence	0.00985	0.0116	CcSEcCtD
Alitretinoin—Acne—Varenicline—nicotine dependence	0.00963	0.0114	CcSEcCtD
Alitretinoin—Eye irritation—Varenicline—nicotine dependence	0.00949	0.0112	CcSEcCtD
Alitretinoin—Tenderness—Varenicline—nicotine dependence	0.00929	0.011	CcSEcCtD
Alitretinoin—Aggression—Varenicline—nicotine dependence	0.00922	0.0109	CcSEcCtD
Alitretinoin—Chest discomfort—Varenicline—nicotine dependence	0.00916	0.0108	CcSEcCtD
Alitretinoin—RARG—brain—nicotine dependence	0.00881	0.0577	CbGeAlD
Alitretinoin—Lacrimation increased—Varenicline—nicotine dependence	0.00879	0.0104	CcSEcCtD
Alitretinoin—Leukocytosis—Varenicline—nicotine dependence	0.00862	0.0102	CcSEcCtD
Alitretinoin—Dysarthria—Varenicline—nicotine dependence	0.00857	0.0101	CcSEcCtD
Alitretinoin—RARA—brain—nicotine dependence	0.00828	0.0542	CbGeAlD
Alitretinoin—Musculoskeletal pain—Varenicline—nicotine dependence	0.0082	0.00968	CcSEcCtD
Alitretinoin—Photophobia—Varenicline—nicotine dependence	0.00761	0.00898	CcSEcCtD
Alitretinoin—Dry eye—Varenicline—nicotine dependence	0.00748	0.00883	CcSEcCtD
Alitretinoin—Oesophagitis—Varenicline—nicotine dependence	0.0074	0.00874	CcSEcCtD
Alitretinoin—Mouth ulceration—Varenicline—nicotine dependence	0.00732	0.00864	CcSEcCtD
Alitretinoin—Euphoric mood—Varenicline—nicotine dependence	0.00696	0.00822	CcSEcCtD
Alitretinoin—Lymphadenopathy—Varenicline—nicotine dependence	0.00689	0.00813	CcSEcCtD
Alitretinoin—Diabetes mellitus—Varenicline—nicotine dependence	0.00676	0.00798	CcSEcCtD
Alitretinoin—Deafness—Varenicline—nicotine dependence	0.00657	0.00776	CcSEcCtD
Alitretinoin—Eczema—Varenicline—nicotine dependence	0.00654	0.00772	CcSEcCtD
Alitretinoin—Renal failure acute—Varenicline—nicotine dependence	0.00637	0.00752	CcSEcCtD
Alitretinoin—Visual disturbance—Varenicline—nicotine dependence	0.00621	0.00732	CcSEcCtD
Alitretinoin—Arthritis—Varenicline—nicotine dependence	0.00605	0.00714	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Varenicline—nicotine dependence	0.006	0.00708	CcSEcCtD
Alitretinoin—Lethargy—Varenicline—nicotine dependence	0.006	0.00708	CcSEcCtD
Alitretinoin—Osteoarthritis—Varenicline—nicotine dependence	0.00588	0.00694	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00588	0.00694	CcSEcCtD
Alitretinoin—Affect lability—Varenicline—nicotine dependence	0.00579	0.00683	CcSEcCtD
Alitretinoin—Psychotic disorder—Varenicline—nicotine dependence	0.00574	0.00678	CcSEcCtD
Alitretinoin—Irritability—Varenicline—nicotine dependence	0.00561	0.00662	CcSEcCtD
Alitretinoin—Mood swings—Varenicline—nicotine dependence	0.00557	0.00657	CcSEcCtD
Alitretinoin—Dry skin—Varenicline—nicotine dependence	0.00539	0.00636	CcSEcCtD
Alitretinoin—Nasopharyngitis—Varenicline—nicotine dependence	0.00526	0.00621	CcSEcCtD
Alitretinoin—Gastritis—Varenicline—nicotine dependence	0.0052	0.00614	CcSEcCtD
Alitretinoin—Abdominal distension—Varenicline—nicotine dependence	0.00512	0.00604	CcSEcCtD
Alitretinoin—Asthma—Varenicline—nicotine dependence	0.00508	0.006	CcSEcCtD
Alitretinoin—Dysphagia—Varenicline—nicotine dependence	0.00508	0.006	CcSEcCtD
Alitretinoin—Abdominal discomfort—Varenicline—nicotine dependence	0.00487	0.00575	CcSEcCtD
Alitretinoin—Pollakiuria—Varenicline—nicotine dependence	0.0047	0.00554	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00464	0.00548	CcSEcCtD
Alitretinoin—Weight increased—Varenicline—nicotine dependence	0.00463	0.00546	CcSEcCtD
Alitretinoin—Infestation NOS—Varenicline—nicotine dependence	0.00453	0.00535	CcSEcCtD
Alitretinoin—Infestation—Varenicline—nicotine dependence	0.00453	0.00535	CcSEcCtD
Alitretinoin—Depression—Varenicline—nicotine dependence	0.00452	0.00533	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00449	0.0053	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Varenicline—nicotine dependence	0.00447	0.00527	CcSEcCtD
Alitretinoin—Myocardial infarction—Varenicline—nicotine dependence	0.00444	0.00524	CcSEcCtD
Alitretinoin—Stomatitis—Varenicline—nicotine dependence	0.00442	0.00521	CcSEcCtD
Alitretinoin—Conjunctivitis—Varenicline—nicotine dependence	0.00441	0.0052	CcSEcCtD
Alitretinoin—Epistaxis—Varenicline—nicotine dependence	0.00427	0.00504	CcSEcCtD
Alitretinoin—Sinusitis—Varenicline—nicotine dependence	0.00425	0.00502	CcSEcCtD
Alitretinoin—Hallucination—Varenicline—nicotine dependence	0.00405	0.00478	CcSEcCtD
Alitretinoin—Hypoaesthesia—Varenicline—nicotine dependence	0.00405	0.00478	CcSEcCtD
Alitretinoin—Urinary tract disorder—Varenicline—nicotine dependence	0.00402	0.00474	CcSEcCtD
Alitretinoin—Oedema peripheral—Varenicline—nicotine dependence	0.00401	0.00473	CcSEcCtD
Alitretinoin—Urethral disorder—Varenicline—nicotine dependence	0.00399	0.00471	CcSEcCtD
Alitretinoin—Visual impairment—Varenicline—nicotine dependence	0.00392	0.00463	CcSEcCtD
Alitretinoin—Erythema multiforme—Varenicline—nicotine dependence	0.00385	0.00454	CcSEcCtD
Alitretinoin—Eye disorder—Varenicline—nicotine dependence	0.0038	0.00449	CcSEcCtD
Alitretinoin—Tinnitus—Varenicline—nicotine dependence	0.00379	0.00448	CcSEcCtD
Alitretinoin—Angiopathy—Varenicline—nicotine dependence	0.00369	0.00436	CcSEcCtD
Alitretinoin—Chills—Varenicline—nicotine dependence	0.00365	0.00431	CcSEcCtD
Alitretinoin—Arrhythmia—Varenicline—nicotine dependence	0.00363	0.00429	CcSEcCtD
Alitretinoin—Mental disorder—Varenicline—nicotine dependence	0.00356	0.00421	CcSEcCtD
Alitretinoin—Erythema—Varenicline—nicotine dependence	0.00354	0.00418	CcSEcCtD
Alitretinoin—Malnutrition—Varenicline—nicotine dependence	0.00354	0.00418	CcSEcCtD
Alitretinoin—Flatulence—Varenicline—nicotine dependence	0.00349	0.00412	CcSEcCtD
Alitretinoin—Back pain—Varenicline—nicotine dependence	0.00343	0.00404	CcSEcCtD
Alitretinoin—Vision blurred—Varenicline—nicotine dependence	0.00334	0.00394	CcSEcCtD
Alitretinoin—Tremor—Varenicline—nicotine dependence	0.00332	0.00392	CcSEcCtD
Alitretinoin—Ill-defined disorder—Varenicline—nicotine dependence	0.00329	0.00388	CcSEcCtD
Alitretinoin—Anaemia—Varenicline—nicotine dependence	0.00327	0.00386	CcSEcCtD
Alitretinoin—Agitation—Varenicline—nicotine dependence	0.00325	0.00384	CcSEcCtD
Alitretinoin—ABCB1—cardiovascular system—nicotine dependence	0.00321	0.021	CbGeAlD
Alitretinoin—Malaise—Varenicline—nicotine dependence	0.00319	0.00377	CcSEcCtD
Alitretinoin—Syncope—Varenicline—nicotine dependence	0.00318	0.00375	CcSEcCtD
Alitretinoin—Palpitations—Varenicline—nicotine dependence	0.00313	0.00369	CcSEcCtD
Alitretinoin—Loss of consciousness—Varenicline—nicotine dependence	0.00311	0.00367	CcSEcCtD
Alitretinoin—Cough—Varenicline—nicotine dependence	0.00309	0.00365	CcSEcCtD
Alitretinoin—Convulsion—Varenicline—nicotine dependence	0.00307	0.00362	CcSEcCtD
Alitretinoin—Hypertension—Varenicline—nicotine dependence	0.00306	0.00361	CcSEcCtD
Alitretinoin—Arthralgia—Varenicline—nicotine dependence	0.00302	0.00356	CcSEcCtD
Alitretinoin—Myalgia—Varenicline—nicotine dependence	0.00302	0.00356	CcSEcCtD
Alitretinoin—Chest pain—Varenicline—nicotine dependence	0.00302	0.00356	CcSEcCtD
Alitretinoin—Anxiety—Varenicline—nicotine dependence	0.003	0.00355	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00299	0.00353	CcSEcCtD
Alitretinoin—Discomfort—Varenicline—nicotine dependence	0.00298	0.00352	CcSEcCtD
Alitretinoin—Dry mouth—Varenicline—nicotine dependence	0.00295	0.00348	CcSEcCtD
Alitretinoin—Oedema—Varenicline—nicotine dependence	0.00289	0.00341	CcSEcCtD
Alitretinoin—Infection—Varenicline—nicotine dependence	0.00287	0.00339	CcSEcCtD
Alitretinoin—Shock—Varenicline—nicotine dependence	0.00284	0.00336	CcSEcCtD
Alitretinoin—Nervous system disorder—Varenicline—nicotine dependence	0.00283	0.00335	CcSEcCtD
Alitretinoin—Thrombocytopenia—Varenicline—nicotine dependence	0.00283	0.00334	CcSEcCtD
Alitretinoin—Tachycardia—Varenicline—nicotine dependence	0.00282	0.00333	CcSEcCtD
Alitretinoin—Skin disorder—Varenicline—nicotine dependence	0.00281	0.00331	CcSEcCtD
Alitretinoin—Hyperhidrosis—Varenicline—nicotine dependence	0.00279	0.0033	CcSEcCtD
Alitretinoin—Anorexia—Varenicline—nicotine dependence	0.00276	0.00325	CcSEcCtD
Alitretinoin—Hypotension—Varenicline—nicotine dependence	0.0027	0.00319	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00263	0.00311	CcSEcCtD
Alitretinoin—Insomnia—Varenicline—nicotine dependence	0.00261	0.00309	CcSEcCtD
Alitretinoin—Dyspnoea—Varenicline—nicotine dependence	0.00258	0.00304	CcSEcCtD
Alitretinoin—Somnolence—Varenicline—nicotine dependence	0.00257	0.00303	CcSEcCtD
Alitretinoin—Dyspepsia—Varenicline—nicotine dependence	0.00254	0.003	CcSEcCtD
Alitretinoin—Decreased appetite—Varenicline—nicotine dependence	0.00251	0.00297	CcSEcCtD
Alitretinoin—ABCB1—midbrain—nicotine dependence	0.0025	0.0164	CbGeAlD
Alitretinoin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0025	0.00295	CcSEcCtD
Alitretinoin—Fatigue—Varenicline—nicotine dependence	0.00249	0.00294	CcSEcCtD
Alitretinoin—Constipation—Varenicline—nicotine dependence	0.00247	0.00292	CcSEcCtD
Alitretinoin—Pain—Varenicline—nicotine dependence	0.00247	0.00292	CcSEcCtD
Alitretinoin—Feeling abnormal—Varenicline—nicotine dependence	0.00238	0.00281	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00236	0.00279	CcSEcCtD
Alitretinoin—Urticaria—Varenicline—nicotine dependence	0.0023	0.00271	CcSEcCtD
Alitretinoin—Abdominal pain—Varenicline—nicotine dependence	0.00228	0.0027	CcSEcCtD
Alitretinoin—Body temperature increased—Varenicline—nicotine dependence	0.00228	0.0027	CcSEcCtD
Alitretinoin—Hypersensitivity—Varenicline—nicotine dependence	0.00213	0.00251	CcSEcCtD
Alitretinoin—Asthenia—Varenicline—nicotine dependence	0.00207	0.00245	CcSEcCtD
Alitretinoin—Pruritus—Varenicline—nicotine dependence	0.00204	0.00241	CcSEcCtD
Alitretinoin—Diarrhoea—Varenicline—nicotine dependence	0.00198	0.00233	CcSEcCtD
Alitretinoin—Dizziness—Varenicline—nicotine dependence	0.00191	0.00226	CcSEcCtD
Alitretinoin—Vomiting—Varenicline—nicotine dependence	0.00184	0.00217	CcSEcCtD
Alitretinoin—Rash—Varenicline—nicotine dependence	0.00182	0.00215	CcSEcCtD
Alitretinoin—Dermatitis—Varenicline—nicotine dependence	0.00182	0.00215	CcSEcCtD
Alitretinoin—Headache—Varenicline—nicotine dependence	0.00181	0.00214	CcSEcCtD
Alitretinoin—Nausea—Varenicline—nicotine dependence	0.00172	0.00203	CcSEcCtD
Alitretinoin—ABCB1—brain—nicotine dependence	0.00157	0.0103	CbGeAlD
